Also from this source

You just read:

Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication

News provided by

Insmed Incorporated

Mar 03, 2011, 08:00 EST